Hand-foot Syndrome Induced by Anti-tumor Drugs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with malignant tumors confirmed by pathology or cytology; (2) Patients with grade I or above HFS after receiving chemotherapy or targeted therapy; (3) KPS score >60; (4) No serious dysfunction of heart liver kidney and other important organs; (5) Expected survival >3 months; (6) Age 18-80 years old; (7) Good compliance; (8) Voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with serious diseases such as heart liver kidney and brain; (2) Patients with other types of diseases in the hands and feet; (3) People with allergies; (4) Currently participating in other Chinese and Western medicine treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HF-QOL;HFS classification; | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS;Inflammatory factor;MDASI-TCM;EORTC QOL C30; | — |
Countries
China
Contacts
Shanghai Fourth People's Hospital affiliated to Tongji University